SEC Form 4 · accession 0000905148-16-001685
CytomX Therapeutics, Inc. · CTMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Frederick W Gluck
Director
Period of report
Apr 5, 2016
Accepted (ET)
Jun 21, 2016 · 6:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001501989
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Apr 5, 2016 | J | 331,643 | $0.00 | A | 331,643 | I | By Frederick W. Gluck 1997 Family Trust dtd July 28, 1997 |
| Common StockF1,F3 | Apr 5, 2016 | J | 17,111 | $0.00 | A | 22,111 | I | By Richlin Partners, LLC |
| Common Stock | holding | — | — | — | 147,791 | D | ||
| Common Stock | holding | — | — | — | 3,200 | I | By spouse |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Pro rata distribution, in-kind and for no consideration, from CytomX Therapeutics Holdings, LLC of which the reporting person is a non-managing member.
- F2The reporting person is a trustee of Frederick W. Gluck 1997 Family Trust dtd July 28, 1997.
- F3Richlin Partners, LLC is an entity owned of record by the spouse of Frederick W. Gluck.
Remarks
Exhibit 24.1 - Power of Attorney (incorporated by reference to the Power of Attorney filed as Exhibit 24.1 to the Form 3 filed by the reporting person on October 7, 2015)